NanO2TM

DRUG2 trials

Sponsors

NuvOx LLC, NHS Greater Glasgow and Clyde

Conditions

Glioblastoma MultiformeStroke Acute

Phase 2

A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

Active, not recruitingNCT03862430

NuvOx LLCGlioblastoma Multiforme

Start: 2023-03-31End: 2027-09-30Target: 87Updated: 2026-08-06

NanO2 in Large VessEL Occlusion Stroke (NOVEL)

Not yet recruitingNCT06821347

NHS Greater Glasgow and ClydeStroke Acute

Start: 2025-05-01End: 2026-07-31Target: 172Updated: 2025-04-04

Related Papers

A phase 2 double-blind, randomized, prospective, placebo-controlled study of NanO₂ combined with radiation and temozolomide in patients with newly diagnosed glioblastoma: RESTORE.

Journal of Clinical Oncology2026-05-27